Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Asset Resilience Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has an Asset Resilience Ratio of 17.40% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600436 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2024)
This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See how leveraged is Zhangzhou Pientzehuang Pharmaceutical Co's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Zhangzhou Pientzehuang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600436 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥3.26 Billion | 17.4% |
| Total Liquid Assets | CN¥3.26 Billion | 17.40% |
Asset Resilience Insights
- Good Liquidity Position: Zhangzhou Pientzehuang Pharmaceutical Co Ltd maintains a healthy 17.40% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.10% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.48% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.46% |
|
Korean Drug Co. Ltd
KQ:014570 |
Drug Manufacturers - General | 12.77% |
|
Chorokbaem Healthcare Co Ltd
KO:118000 |
Drug Manufacturers - General | 0.11% |
Annual Asset Resilience Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual Asset Resilience Ratio data for Zhangzhou Pientzehuang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 20.07% | CN¥3.52 Billion ≈ $515.03 Million |
CN¥17.54 Billion ≈ $2.57 Billion |
-33.14pp |
| 2023-12-31 | 53.21% | CN¥9.09 Billion ≈ $1.33 Billion |
CN¥17.08 Billion ≈ $2.50 Billion |
+53.14pp |
| 2021-12-31 | 0.07% | CN¥8.80 Million ≈ $1.29 Million |
CN¥12.50 Billion ≈ $1.83 Billion |
+0.07pp |
| 2020-12-31 | 0.00% | CN¥13.37K ≈ $1.96K |
CN¥10.21 Billion ≈ $1.49 Billion |
0.00pp |
| 2019-12-31 | 0.00% | CN¥19.22K ≈ $2.81K |
CN¥8.81 Billion ≈ $1.29 Billion |
0.00pp |
| 2018-12-31 | 0.00% | CN¥46.84K ≈ $6.85K |
CN¥6.66 Billion ≈ $974.24 Million |
+0.00pp |
| 2017-12-31 | 0.00% | CN¥24.29K ≈ $3.55K |
CN¥5.65 Billion ≈ $826.52 Million |
0.00pp |
| 2016-12-31 | 0.00% | CN¥134.97K ≈ $19.75K |
CN¥5.04 Billion ≈ $737.19 Million |
+0.00pp |
| 2013-12-31 | 0.00% | CN¥42.56K ≈ $6.23K |
CN¥3.26 Billion ≈ $476.94 Million |
+0.00pp |
| 2011-12-31 | 0.00% | CN¥838.64 ≈ $122.72 |
CN¥1.57 Billion ≈ $229.55 Million |
-0.01pp |
| 2010-12-31 | 0.01% | CN¥94.31K ≈ $13.80K |
CN¥1.45 Billion ≈ $211.72 Million |
-0.39pp |
| 2009-12-31 | 0.39% | CN¥5.05 Million ≈ $738.37K |
CN¥1.28 Billion ≈ $187.97 Million |
+0.05pp |
| 2006-12-31 | 0.34% | CN¥2.49 Million ≈ $364.22K |
CN¥730.62 Million ≈ $106.91 Million |
-0.74pp |
| 2005-12-31 | 1.09% | CN¥7.53 Million ≈ $1.10 Million |
CN¥693.63 Million ≈ $101.50 Million |
-1.93pp |
| 2004-12-31 | 3.01% | CN¥16.83 Million ≈ $2.46 Million |
CN¥558.77 Million ≈ $81.77 Million |
-18.31pp |
| 2003-12-31 | 21.32% | CN¥126.88 Million ≈ $18.57 Million |
CN¥594.99 Million ≈ $87.07 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals… Read more